Wednesday, September 20, 2017

FDA Clears Liquid Extended-Release Amphetamine for ADHD - Medscape


Medscape

FDA Clears Liquid Extended-Release Amphetamine for ADHD
Medscape
The US Food and Drug Administration (FDA) has approved amphetamine extended-release oral suspension (Adzenys ER, Neos Therapeutics Inc) for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the company has ...
FDA OKs ADHD MedicationPharmacy Times
Neos Therapeutics shares down, despite FDA approval of ADHD drugThe Pharma Letter (registration)
Neos Therapeutics ADHD Drug Adzenys Receives Approval in USZacks.com
Monthly Prescribing Reference (registration) -pharmabiz.com -Investing News Update
all 43 news articles »

“Stop Pushing Your Kid to Be Normal” - ADDitude


ADDitude

“Stop Pushing Your Kid to Be Normal”
ADDitude
It's no secret that kids with ADHD are different — different from their same-age peers; different from society's definition of “normal;” different from most teachers' expectations of a successful student. Yet we expect kids to “fall in line” and fit ...

Mydayis improves ADHD, functioning in adults - Healio - Healio


Mydayis improves ADHD, functioning in adults - Healio
Healio
NEW ORLEANS — Data presented here indicated efficacy and safety of Mydayis, a once-daily mixed salts of a single-entity amphetamine product, for ADHD in ...

and more »

ADHD the Focus of International Conference Hosted by CHADD and ... - Business Wire (press release)


ADHD the Focus of International Conference Hosted by CHADD and ...
Business Wire (press release)
The 2017 Annual International Conference on ADHD, hosted by CHADD and ADDA, will be held in Atlanta, November 9 - 12.

and more »

KemPharm Files IND for KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate - Markets Insider


KemPharm Files IND for KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate
Markets Insider
“In the process of re-analyzing the Phase 1 data for KP415, our co-lead investigation prodrug of d-MPH for the treatment of ADHD, we observed properties and a drug release profile in KP484 that we believe allows for the possible development of a much ...

Smoking Risks for Female Adolescents with ADHD in Childhood - Psychiatry Advisor


Smoking Risks for Female Adolescents with ADHD in Childhood
Psychiatry Advisor
Children with more severe symptoms of attention deficit hyperactivity disorder (ADHD) are more likely to smoke cigarettes by age 17 and to start smoking at an earlier age, researchers reported in AJP in Advance.1. According to the report, nicotine is ...

KemPharm Files IND for KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate - Nasdaq


KemPharm Files IND for KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate
Nasdaq
"In the process of re-analyzing the Phase 1 data for KP415, our co-lead investigation prodrug of d-MPH for the treatment of ADHD, we observed properties and a drug release profile in KP484 that we believe allows for the possible development of a much ...